Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 30% ± 8% | |
hematopoietic precursor cell | 3 studies | 20% ± 3% | |
endothelial cell | 3 studies | 21% ± 5% | |
ciliated cell | 3 studies | 25% ± 8% | |
dendritic cell | 3 studies | 24% ± 4% | |
astrocyte | 3 studies | 23% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3444.33 | 1445 / 1445 | 100% | 39.97 | 183 / 183 |
intestine | 100% | 3581.73 | 966 / 966 | 100% | 32.65 | 527 / 527 |
lung | 100% | 3538.02 | 578 / 578 | 100% | 28.73 | 1155 / 1155 |
ovary | 100% | 5538.47 | 180 / 180 | 100% | 36.39 | 430 / 430 |
prostate | 100% | 4470.10 | 245 / 245 | 100% | 28.52 | 502 / 502 |
stomach | 100% | 2835.00 | 359 / 359 | 100% | 34.52 | 286 / 286 |
uterus | 100% | 4866.64 | 170 / 170 | 100% | 36.05 | 459 / 459 |
skin | 100% | 3418.59 | 1808 / 1809 | 100% | 33.05 | 472 / 472 |
breast | 100% | 3229.34 | 459 / 459 | 100% | 31.13 | 1117 / 1118 |
bladder | 100% | 3689.48 | 21 / 21 | 100% | 30.18 | 503 / 504 |
thymus | 100% | 3837.15 | 653 / 653 | 100% | 27.56 | 603 / 605 |
kidney | 100% | 3471.38 | 89 / 89 | 99% | 19.40 | 896 / 901 |
brain | 99% | 2776.07 | 2625 / 2642 | 100% | 29.75 | 705 / 705 |
liver | 100% | 2221.85 | 226 / 226 | 99% | 15.16 | 403 / 406 |
pancreas | 99% | 2234.18 | 326 / 328 | 99% | 22.18 | 176 / 178 |
adrenal gland | 100% | 3364.18 | 258 / 258 | 97% | 18.63 | 224 / 230 |
adipose | 100% | 3212.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 29.91 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 42.18 | 29 / 29 |
spleen | 100% | 4741.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.06 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.65 | 1 / 1 |
blood vessel | 100% | 3205.15 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2239.51 | 855 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 2127.11 | 792 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 2719.37 | 874 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902151 | Biological process | regulation of response to DNA integrity checkpoint signaling |
GO_0045087 | Biological process | innate immune response |
GO_0007369 | Biological process | gastrulation |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0009725 | Biological process | response to hormone |
GO_0046600 | Biological process | negative regulation of centriole replication |
GO_0002218 | Biological process | activation of innate immune response |
GO_0006915 | Biological process | apoptotic process |
GO_0098534 | Biological process | centriole assembly |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003729 | Molecular function | mRNA binding |
GO_1990935 | Molecular function | splicing factor binding |
GO_0003723 | Molecular function | RNA binding |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RBM14 |
Protein name | RNA binding motif protein 14 isoform 1 RNA binding motif protein 14 isoform 2 RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein) RNA binding motif protein 14 isoform 3 RNA binding motif protein 14 |
Synonyms | SIP |
Description | FUNCTION: Isoform 1 may function as a nuclear receptor coactivator, enhancing transcription through other coactivators such as NCOA6 and CITED1. Isoform 2, functions as a transcriptional repressor, modulating transcriptional activities of coactivators including isoform 1, NCOA6 and CITED1 . Regulates centriole biogenesis by suppressing the formation of aberrant centriolar protein complexes in the cytoplasm and thus preserving mitotic spindle integrity. Prevents the formation of the STIL-CENPJ complex (which can induce the formation of aberrant centriolar protein complexes) by interfering with the interaction of STIL with CENPJ . Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway . Also involved in the regulation of pre-mRNA alternative splicing . . |
Accessions | ENST00000310137.5 [Q96PK6-1] A0A0S2Z4Z0 B8ZZ74 ENST00000393979.3 [Q96PK6-2] F8WDX3 A0A0S2Z5V2 ENST00000409372.1 ENST00000443702.1 ENST00000409738.4 [Q96PK6-4] Q96PK6 A0A0S2Z567 |